Key Takeaways
📈 MetLife offers a 2.84% dividend yield with a conservative 46.4% payout ratio, supported by steady annual increases and strong operational cash generation.
💰 The company generated $17.1 billion in operating cash flow over the trailing twelve months, providing ample coverage for dividends and ongoing share repurchases.
🔍 Analysts remain constructive, with a consensus buy rating across 15 firms and a mean price target of $91.73, implying meaningful upside from the current price of $75.24.
Updated 2/24/26
MetLife, Inc. (MET) stands as one of the largest and most financially sound insurance providers globally, with a legacy rooted in over a century of delivering life insurance, annuities, employee benefits, and asset management. Its consistent operating performance, disciplined capital management, and strong balance sheet make it a reliable choice for income-focused investors.
The company’s forward-looking strategy emphasizes risk-adjusted growth, shareholder returns, and efficient execution. With over $17 billion in operating cash flow, a 2.84% dividend yield supported by a 46.4% payout ratio, and a leadership team deeply experienced in navigating complex markets, MetLife offers a compelling blend of income stability and financial strength.
Recent Events
MetLife has continued its steady operational cadence heading into early 2026, with the most recent quarterly dividend payment of $0.568 per share delivered on February 3, 2026. That payment held steady from the prior three quarters, maintaining the annualized rate at $2.272 per share following the increase that took effect in May 2025. Revenue over the trailing twelve months reached approximately $77.1 billion, while net income came in at roughly $3.2 billion, reflecting a net margin of 4.4% that is characteristic of large diversified insurers managing significant investment portfolios alongside their underwriting businesses.
The stock has pulled back from its 52-week high of $87.39 and is currently trading near $75.24, sitting close to the low end of its one-year range of $65.21 to $87.39. That positioning, combined with a beta of just 0.74, reflects MetLife’s tendency to absorb broader market turbulence with less dramatic price swings than the overall equity market. Operating cash flow of $17.1 billion over the trailing twelve months represents a meaningful improvement from prior periods and continues to underpin the company’s capacity to fund dividends, buybacks, and strategic investments simultaneously.
Return on equity came in at 12.0%, a solid figure for a large-cap insurer, and the company’s book value per share now stands at $43.33, placing the current price-to-book ratio at approximately 1.74. Short interest sits at roughly 10.9 million shares, a modest figure relative to the float that does not suggest any significant bearish conviction among market participants. The overall picture is one of a business executing consistently while the stock price temporarily lags underlying business performance, a dynamic that dividend growth investors tend to find attractive.
Key Dividend Metrics
📈 Dividend Yield: 2.84%
💸 Annual Dividend Rate: $2.27
🔒 Payout Ratio: 46.42%
📆 Ex-Dividend Date: February 3, 2026
💰 Most Recent Dividend Payment: $0.568 per share
📊 5-Year Average Yield: 3.17%
🛡️ Cash Flow Coverage: Strong, with $17.1B in trailing 12-month operating cash flow
📉 Debt Load: Well-supported relative to operating cash generation
📈 Dividend Growth: Steady and consistent, with a raise implemented in May 2025
Dividend Overview
MetLife is not a yield-maximizer, but what it does deliver is a dependable income stream backed by substantial financial resources. At 2.84%, the current yield sits modestly below the company’s five-year average of approximately 3.17%, though much of that gap reflects stock price appreciation rather than any stagnation in the dividend itself. The payout ratio of 46.4% against trailing earnings leaves a comfortable buffer for continued payments and future growth, even if earnings face short-term pressure.
The dividend is well-supported by the income statement and cash flow alike. Operating cash flow of $17.1 billion dwarfs the annual dividend obligation, and the company’s earnings per share of $4.85 easily covers the $2.27 annual payment. This is not a situation where management is stretching to satisfy income investors. The numbers reflect a business that generates genuine, recurring cash from its core operations.
MetLife’s approach to its dividend has always been methodical rather than aggressive. Raises come when the business warrants them, not in response to investor pressure or competitive optics. The quarterly rate moved from $0.545 to $0.568 beginning in May 2025, a 4.2% increase that carries the characteristic discipline this management team consistently demonstrates. For income investors building a portfolio around reliability, that kind of measured approach ages well.
Dividend Growth and Safety
Dividend growth at MetLife has followed a deliberate, upward path over the past several years. The per-share quarterly payment moved from $0.52 in 2023 to $0.545 in mid-2024, then to $0.568 in May 2025, where it has remained through the most recent February 2026 payment. That progression represents cumulative growth of roughly 9.2% from the $0.52 base over approximately two and a half years, a pace that outstrips inflation and reflects genuine earnings-driven growth rather than a stretched payout policy.
The payout ratio of 46.4% is higher than the figure cited in prior reports, primarily because reported net income has moderated relative to the dividend level rather than because the dividend has grown unsustainably. With EPS at $4.85 and the annual dividend at $2.27, there remains meaningful headroom for continued increases. The company does not need an exceptional year to sustain its current payment, which is an important baseline for safety-focused analysis.
Valuation provides additional context for safety. At a trailing price-to-earnings ratio of 15.51 and a price-to-book of 1.74, the stock trades at multiples that are reasonable for a large, diversified insurer with consistent earnings power. These are not inflated multiples that imply fragility. Book value per share of $43.33 gives the current price a tangible anchor, and return on equity of 12.0% confirms the company is generating respectable returns on that capital base.
The overall dividend safety picture is sound. Operating cash flow of $17.1 billion provides coverage many times over the aggregate annual dividend cost, and the company has demonstrated through multiple rate cycles and economic environments that its capital management framework is built to protect shareholder returns even during periods of stress.
Analyst Ratings
Analyst sentiment on MetLife remains firmly constructive as of February 2026. Across 15 covering analysts, the consensus rating is buy, reflecting broad agreement that the company’s earnings profile, capital return program, and valuation represent an attractive combination for investors. The mean price target of $91.73 implies approximately 22% upside from the current price of $75.24, a gap that suggests the street views the recent pullback as an opportunity rather than a warning signal.
The range of analyst price targets spans from a low of $75.00 to a high of $103.00, which reflects meaningful dispersion in views about the pace of earnings recovery and the interest rate environment’s impact on investment income. The low-end target sitting essentially at the current price implies that even the most cautious analysts on the street are not calling for meaningful downside from here. The high-end target of $103.00 reflects what a more optimistic scenario of earnings acceleration and multiple expansion could deliver.
The underlying themes driving analyst confidence are consistent across most coverage notes. Strong operating cash flow, a disciplined payout strategy, reasonable valuation multiples, and management’s track record of executing on capital return commitments all feature prominently in bull cases. Concerns tend to center on the interest rate and credit cycle sensitivity of the investment portfolio, as well as potential headwinds from international segments. Those reservations explain why the stock has drifted lower even as the business has continued to perform, but they have not been enough to shift the consensus away from a buy rating.
For dividend investors, the analyst setup is encouraging. A mean target of $91.73 against a current price of $75.24 means income investors are being paid a 2.84% yield while waiting for a price re-rating that the broad analyst community views as the base case over the next twelve months.
Earning Report Summary
MetLife’s trailing twelve-month financials reflect a business operating at substantial scale with steady underlying profitability. Revenue reached approximately $77.1 billion, encompassing premiums, fees, and net investment income across the company’s global operating segments. Net income for the period came in at roughly $3.2 billion, translating to earnings per share of $4.85. While the net margin of 4.4% appears modest in isolation, it is typical of large diversified insurers that run high-revenue, asset-intensive models where investment portfolio management is as important as underwriting performance.
Return on equity of 12.0% represents a solid result for a company of MetLife’s scale and business mix, indicating that the capital base is being deployed productively. Return on assets came in at 0.46%, which is consistent with the low-asset-turnover, high-capital structure that defines the insurance industry. Operating cash flow of $17.1 billion was the standout figure in the trailing period, underscoring that the company’s cash generation capacity meaningfully exceeds what the reported net income figure alone would suggest.
Focus on Shareholder Value
MetLife’s capital return program has remained a consistent feature of its financial strategy. The dividend increase implemented in May 2025, lifting the quarterly rate from $0.545 to $0.568, was accompanied by continued share repurchase activity. With operating cash flow running at $17.1 billion on a trailing basis, management has considerable flexibility to simultaneously fund the dividend, execute buybacks, and maintain the investment portfolio discipline that drives long-term earnings quality. Book value per share of $43.33 reflects accumulated capital strength that supports both the current payout and future increases.
Segment Highlights
MetLife’s diversified segment structure spans Group Benefits, Retirement and Income Solutions, Asia, Latin America, and corporate operations, providing geographic and product diversification that smooths earnings volatility across economic cycles. The Group Benefits segment has historically been a strong contributor, benefiting from favorable underwriting trends in employer-sponsored life and disability insurance. Retirement and Income Solutions continues to see steady demand as demographic tailwinds support annuity and income product uptake among aging populations in MetLife’s core markets.
International segments, particularly Asia, have historically introduced both opportunity and variability. Currency movements, local regulatory changes, and differences in underwriting conditions across markets can cause period-to-period fluctuations that do not reflect any structural deterioration in the underlying businesses. Management’s ongoing focus on optimizing the geographic portfolio, including the strategic use of reinsurance to manage tail risk, reflects a disciplined approach to protecting earnings quality across the full enterprise.
Looking Ahead
MetLife enters 2026 with an operating cash flow profile that provides a strong platform for continued dividend growth and capital returns. Management’s stated priorities around responsible growth, risk management, and shareholder value creation have been consistently demonstrated through the dividend increase trajectory and capital return activity of the past several years. The current pullback in the stock price, with shares near $75.24 against a mean analyst target of $91.73, sets up an interesting dynamic for long-term income investors considering a position at current levels.
The company’s ability to sustain and grow its dividend does not depend on outsized earnings growth. The combination of a manageable payout ratio, strong operating cash flow, and a conservative balance sheet means that even in a more challenging economic environment, MetLife’s dividend program has significant protection. That is the kind of structural resilience that dividend growth investors should find reassuring.
Management Team
MetLife’s leadership team is composed of seasoned professionals who bring deep experience and steady hands to the company’s operations. Michel A. Khalaf leads as President and Chief Executive Officer, steering the company’s long-term strategic direction with a consistent emphasis on disciplined capital management and sustainable shareholder returns. John D. McCallion, Executive Vice President and Chief Financial Officer, oversees the firm’s financial framework and capital deployment strategies, ensuring that operating cash flow is allocated efficiently across dividends, buybacks, and portfolio investment.
Supporting the team is Marlene Debel, Executive Vice President and Chief Risk Officer, responsible for identifying and managing key risk exposures across the business. Monica M. Curtis, Executive Vice President and Chief Legal Officer, ensures the company’s legal affairs are aligned with its global operations, while Bill Pappas, Executive Vice President and Head of Global Technology and Operations, drives innovation and digital transformation across the enterprise. Together, this leadership team has helped MetLife maintain its focus on operational efficiency, shareholder value, and long-term stability through varying economic and market conditions.
Valuation and Stock Performance
MetLife’s stock is currently trading at $75.24, near the lower end of its 52-week range of $65.21 to $87.39. The pullback from the $87.39 high represents a meaningful compression from where the stock was trading at its recent peak, and it has created a valuation setup that looks increasingly attractive relative to the company’s earnings and cash flow profile. A trailing price-to-earnings ratio of 15.51 and a price-to-book of 1.74 are both reasonable multiples for a large-cap insurer with consistent earnings power, a 12% return on equity, and over $17 billion in annual operating cash flow.
The gap between the current price and the analyst consensus target of $91.73 is one of the more notable features of the current setup. A 22% implied upside to the mean target, combined with a 2.84% dividend yield, translates to a compelling total return potential for investors willing to be patient. The market cap of approximately $49.6 billion reflects a business that the street is currently pricing conservatively relative to its earnings capacity. For long-term income investors, buying a consistently profitable, dividend-growing insurer at or near the low end of its annual range, while collecting a yield that is supported by $17 billion in operating cash flow, represents the kind of setup that tends to reward patience.
Risks and Considerations
MetLife operates in a heavily regulated industry, and changes in domestic or international insurance regulations, capital requirement frameworks, or tax treatment of insurance products can influence both profitability and strategic flexibility. The company’s global footprint means it must continuously monitor and adapt to regulatory developments across dozens of jurisdictions, and a significant policy shift in a major market like Japan or Mexico could have meaningful earnings implications for the affected segment.
Interest rate sensitivity is a central risk for any large insurer managing a substantial fixed income investment portfolio. A prolonged low-rate environment compresses net investment income, while a rapid rate spike can create mark-to-market pressure on the investment portfolio. MetLife’s investment income is a core component of its earnings, and the trajectory of rates therefore matters considerably to both reported results and dividend growth capacity over multi-year horizons.
The company’s international exposure, particularly in Asia and Latin America, introduces currency translation risk and geopolitical variability that can cause earnings to fluctuate in ways that are disconnected from underlying business performance. While geographic diversification is generally a strength, it also means that local conditions in any single market can create segment-level volatility that weighs on reported consolidated results even when the core domestic business is performing well. Competitive intensity across all of MetLife’s product lines requires ongoing investment in technology, distribution, and service capabilities, which creates a need for continued capital allocation discipline to avoid margin erosion over time.
Final Thoughts
MetLife continues to position itself as a dependable player in the insurance and financial services space. The leadership team’s discipline, the firm’s solid earnings profile, and its exceptional operating cash flow give the company room to navigate industry challenges while returning value to shareholders in a consistent and predictable manner. The dividend increase implemented in May 2025, lifting the quarterly payment to $0.568, reflects management’s ongoing commitment to growing the income stream alongside the business rather than simply maintaining it.
With the stock trading near $75.24 against a mean analyst target of $91.73, a conservative payout ratio of 46.4%, and operating cash flow running at $17.1 billion, the current entry point offers income investors a meaningful combination of yield, growth potential, and total return upside. This is not a high-growth story, and it was never meant to be. It is a story about consistency, financial strength, and the quiet compounding that comes from owning a well-run insurer at a reasonable price. For dividend-focused portfolios seeking that kind of reliable foundation, MetLife remains a compelling consideration.